Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets

Acta Oncologica

Volumn 52, Issue 3, 2013, Pages 521-527

  Thörnqvist, Sara ^a   Muren, Ludvig P ^a   Bentzen, Lise ^a   Hysing, Liv B ^b   Hoyer, Morten ^a   Grau, Cai ^a   Petersen, Jorgen B B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCULATION; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL EFFECTIVENESS; EVALUATION; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED PROTON THERAPY; INTENSITY MODULATED RADIATION THERAPY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TREATMENT PLANNING; ANATOMICAL VARIATION; BLADDER CAPACITY; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; IMAGE ANALYSIS; PELVIS LYMPH NODE; RECTUM; SEMINAL VESICLE; TREATMENT OUTCOME; VOLUME OF DISTRIBUTION;

COMPUTER SIMULATION; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MOTION; ORGAN SIZE; PATIENT POSITIONING; PELVIS; PROSTATE; PROSTATIC NEOPLASMS; PROTON THERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY SETUP ERRORS; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER;

EID: 84875178377     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.752860     Document Type: Article

References (33)

1. Dearnaley D P, S ydes M R, G raham J D, A ird E G, Bottomley D, Cowan RA, et al . Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial . Lancet Oncol 2007; 8 : 475-87 (Pubitemid 46805903)
2. Peeters S T, H eemsbergen W D, v an Putten W L, S lot A, Tabak H, Mens JW, et al . Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy . Int J Radiat Oncol Biol Phys 2005; 61 : 1019-34 (Pubitemid 40340897)
3. Coen JJ, B ae K, Z ietman AL, P atel B, S hipley WU, S later JD, et al . Acute and late toxicity after dose escalation to 82 GyE using conformal proton radiation for localized prostate cancer: Initial report of American College of Radiology Phase II study 03-12 . Int J Radiat Oncol Biol Phys 2011; 81 : 1005-9
4. Coen J J, P aly J J, N iemierko A, W eyman E, R odrigues A, Shipley WU, et al . Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer . Int J Radiat Oncol Biol Phys 2012; 82 : 201-9
5. Olsen DR, B ruland OS, F rykholm G, N orderhaug IN. P roton therapy-a systematic review of clinical effectiveness . Radiother Oncol 2007; 83 : 123-32 (Pubitemid 46776914)
6. Nystr öm H, B lomqvist E, H ø y er M, M ontelius A, M uren LP, Nilsson P, et al . Particle therapy-a next logical step in the improvement of radiotherapy . Acta Oncol 2011 ; 50 : 741-4
7. Vargas C, Wagner M, Mahajan C, Indelicato D, Fryer A, Falchook A, et al . Proton therapy coverage for prostate Prostate cancer treatment . Int J Radiat Oncol Biol Phys 2008; 70 : 1492-501 (Pubitemid 351417764)
8. Zietman AL, Bae [8] K, S later JD, S hipley WU, E fstathiou JA, Coen JJ, et al . Randomized trial comparing conventionaldose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College Of Radiology 95-09 . J Clin Oncol 2010; 28 : 1106-11
9. Wang D, L awton C. Pelvic lymph node irradiation for prostate cancer: Who, why, and when . Semin Radiat Oncol 2008; 18 : 35-40 (Pubitemid 350235954)
10. Widesott L, P ierelli A, F iorino C, L omax AJ, Amichetti M, Cozzarini C, et al . Helical tomotherapy versus intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: Dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis . Int J Radiat Oncol Biol Phys 2011; 80 : 1589-600
11. Lassen-Ramshad Y, V estergaard A, M uren L P, H ø y er M, Petersen JB . Plan robustness in proton beam therapy of a childhood brain tumour . Acta Oncol 2011; 50 : 791-6
12. Johansson B, R idderheim M, G limelius B. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers . Acta Oncol 2005; 44 : 890-5 (Pubitemid 41780116)
13. Allen AM, P awlicki T, D ong L, F ourkal E, B uyyounouski M, Cengel K, et al . An evidence based review of proton beam therapy: The report of ASTRO's emerging technology committee . Radiother Oncol 2012; 103 : 8-11
14. Chera B S, V argas C, M orris C G, L ouis D, F lampouri S, Yeung D, et al . Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer . Int J Radiat Oncol Biol Phys 2009; 75 : 994-1002
15. Schippers J M, L omax AJ. E merging technologies in proton therapy . Acta Oncol 2011; 50 : 838-50
16. Liang J, W u Q, Y an D. The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer . Int J Radiat Oncol Biol Phys 2009; 73 : 935-43
17. Th ör nqvist S, B entzen L, P etersen J B, H ysing L B, Muren LP . Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques . Acta Oncol 2011; 50 : 926-34
18. Th ör nqvist S, P etersen JB, H ø y er M, B entzen L, M uren LP. Propagation of target and organ at risk contours in radiotherapy of prostate cancer using deformable image registration . Acta Oncol 2010; 49 : 1023-32
19. Lomax A, P edroni E, S chaffner B, S cheib S, S chneider U, Tourovsky A . 3D treatment planning for conformal proton therapy by spotscanning . In : Faulkner K, Carey B, Crellin A, Harrison RM, editors. Quantitative imaging in oncology. London: BIR Publishing; 1996 . p. 67-71
20. International Commission on Radiation Units and Measurements . Prescribing, recording and reporting proton-beam therapy (ICRU Report 78) . J ICRU 2007; 7
21. Andersen ES, M uren LP, S ør ensen T S, N oe KO, T hor M, Petersen JB, et al . Bladder dose accumulation based on a biomechanical deformable image registration algorithm in volumetric modulated arc therapy for prostate cancer . Phys Med Biol 2012; 57 : 7089-100
22. Niemierko A. R eporting and analyzing dose distributions: A concept of equivalent uniform dose . Med Phys 1997; 24 : 103-10 (Pubitemid 27051935)
23. Niemierko A. A generalized concept of equivalent uniform dose . Med Phys 1999; 26 : 1000 (Abstract)
24. S ø vik Å, O vrum J, O lsen DR, M alinen E. O n the parameter describing the generalised equivalent uniform dose (gEUD) for tumours . Phys Med 2002; 23 : 100-6 (Pubitemid 350166994)
25. Zhang X, D ong L, L ee AK, C ox JD, K uban DA, Z hu RX, et al . Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment . Int J Radiat Oncol Biol Phys 2007; 67 : 620-9 (Pubitemid 46108332)
26. Soukup M, S öh n M, Y an D, L iang J, A lber M. S tudy of robustness of IMPT and IMRT for prostate cancer against organ movement . Int J Radiat Oncol Biol Phys 2009; 75 : 941-9
27. Smeenk RJ, T eh BS, B utler EB, v an Lin EN, K aanders JH . Is there a role for endorectal balloons in prostate radiotherapy? A systematic review. Radiother Oncol 2010; 95 : 277-82
28. Lomax AJ. I ntensity modulated proton therapy and its sensitivity to treatment uncertainties 2: The potential effects of inter-fraction and inter-fi eld motions . Phys Med Biol 2008; 53 : 1043-56 (Pubitemid 351238122)
29. Park P C, Z hu X R, L ee AK, S ahoo N, M elancon AD, Zhang L, et al . A beam-specifi c planning target volume (PTV) design for proton therapy to account for setup and range uncertainties . Int J Radiat Oncol Biol Phys 2012; 82 : 329-36
30. De Ruysscher D, M ark Lodge M, J ones B, B rada M, Munro A, Jefferson T, et al . Charged particles in radiotherapy: A 5-year update of a systematic review . Radiother Oncol 2012; 103 : 5-7
31. Nihei K, O gino T, O nozawa M, M urayama S, F uji H, Murakami M, et al . Multi-institutional phase II study of proton beam therapy for organ-confi ned prostate cancer focusing on the incidence of late rectal toxicities . Int J Radiat Oncol Biol Phys 2011; 81 : 390-6
32. Trofi mov A, N guyen PL, E fstathiou JA, W ang Y, L u HM, Engelsman M, et al . Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer . Int J Radiat Oncol Biol Phys 2011 ; 80 : 928-37
33. Stuschke M, Kaiser A, P öt tgen C, Lü b cke W, Farr J . Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans . Radiother Oncol 2012; 104 : 45-51